Increased activation of the ERK/MAPK signaling pathway can promote the transformation of normal cells into cancer cells, whereas inhibition of the ERK/MAPK signaling pathway can revert cancer cells to a non-transformed state in vitro and can inhibit tumor growth in vivo. The gene discussed is MAPK1; the disease is cancer.